A carregar...
Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas
The Epstein-Barr virus (EBV) is one of the predominant tumor viruses in humans, but so far no therapeutic or prophylactic vaccination against this transforming pathogen is available. We demonstrated that heterologous prime-boost vaccination with the nuclear antigen 1 of EBV (EBNA1), either targeted...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486346/ https://ncbi.nlm.nih.gov/pubmed/31042161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI125364 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|